Search Results 61-70 of 16408 for Glucocorticoid

  1. Focus Areas - Epigenomics of Metabolic Diseases: Zong Wei - Mayo Clinic Research

    Epigenetic modulation of glucocorticoid signaling in inflammation. Because ... glucocorticoid action in multiple inflammatory disease models. Given the ...

  2. Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery - Mayo Clinic

    ... glucocorticoid regulated kinase 1 [SGK1], and glycogen synthase kinase 3 beta [GSK3b]) to be developed as a biomarker for use in diagnosis of Cushing's ...

  3. Endoscopic Pituitary Surgery Clinical Trials - Mayo Clinic Research

    The primary purpose of this study is to determine pre-surgical and post-surgical predictors of the duration and severity of glucocorticoid withdrawal in ...

  4. Mayo Clinic Comprehensive Cancer Center — Research

    Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production. Rochester, Minn ...

  5. Fluticasone (Nasal Route) Proper Use - Mayo Clinic

    For chronic rhinosinusitis with or without nasal polyps (CRSwNP):. For nasal dosage form (spray):. Xhance®: Adults—At first, 1 or 2 sprays in each nostril 2 ...

  6. Granulomatous Vasculitis Clinical Trials - Mayo Clinic Research

    Multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of abatacept to achieve sustained glucocorticoid-free remission in ...

  7. Myopathy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the effectiveness, safety and tolerability of ASP0367 in participants with Primary Mitochondrial Myopathy (PMM).

  8. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

    ... glucocorticoid-sparing therapy in patients relying on oral glucocorticoids to manage severe asthma associated with eosinophilia. Read More on PubMed ...

  9. Metyrapone for Mild Autonomous Cortisol Secretion - Mayo Clinic

    Planned use of oral exogenous glucocorticoid therapy. Planned use of opioid therapy > 20 MME/day. Use of injectable glucocorticoid within the last 6 weeks.

  10. Adult Still disease - Symptoms and causes - Mayo Clinic

    Glucocorticoid-induced osteoporosis. Endocrine Society. https://www.endocrine.org/patient-engagement/endocrine-library/glucocorticoid-induced-osteoporosis.